Best Practices: Managing cGMP Formal Failure Investigations and the Closed Loop CAPA System

Jan. 27, 2010 - PRLog -- During FDA audits, Investigators are continuing to review failure investigation reports and evaluate the effectiveness of the FDA regulated firm’s CAPA System. FDA audits the firm’s procedures and failure investigation documentation and pays close attention to the firm’s ability to identify, investigate, and correct unexpected issues in a timely manner. The firm must also demonstrate that their corrective actives were effective so the issue does not reoccur and product was not impacted. Still firms are continually faced with FDA 483s, since FDA Investigators still observe the use non compliant Failure Investigation and CAPA procedures, firms not following their procedure, as well as firms are unable to defend their investigations, conclusions, and corrective actions. The purpose of this teleseminar is to review the following areas:
1) Overview of FDA Requirements
2) Define and Document the Problem
3) Performing Effective Investigations
4) Identifying Root Cause and Conclusion
5) Corrective and Preventive Action (CAPA)
6) Link to Product Release and Product Impact
7) Properly documenting Failure Investigation reports
8) Avoiding Common Pitfalls

Note: Power point Slides and free 14 day audio podium playback provided for those who register.

WHEN: Wednesday, February 3rd, 2010 from 12pm to 1pm, EST

WHERE: Teleseminar session on Bridge line
Admission: All levels of Management for all departments QA/QC/Compliance/Regulatory Affairs Marketing & Sales Engineering/Technical Services Consultants Operations and Manufacturing. Paid Registration.
Registration: http://fdateleseminars.com/Register.html

# # #

Leading provider of teleseminars and webinars with industry experts based on quality assurance, regulatory compliance and clinical to the Medical Device, Pharmaceutical and Food industries.